AKN-028   Click here for help

GtoPdb Ligand ID: 7969

Synonyms: AKN 028 | AKN028
Compound class: Synthetic organic
Comment: AKN-028 is an orally bioavailable protein tyrosine kinase inhibitor for FMS-related tyrosine kinase 3 (FLT3) and stem cell factor receptor (SCFR; KIT), that was developed for potential antineoplastic activity [1-2]. The compound inhibits wild-type and mutant FLT3 and KIT kinases.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 3
Rotatable bonds 3
Topological polar surface area 92.51
Molecular weight 302.13
XLogP 2.3
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES Nc1ncc(nc1Nc1ccc2c(c1)cc[nH]2)c1ccncc1
Isomeric SMILES Nc1ncc(nc1Nc1ccc2c(c1)cc[nH]2)c1ccncc1
InChI InChI=1S/C17H14N6/c18-16-17(22-13-1-2-14-12(9-13)5-8-20-14)23-15(10-21-16)11-3-6-19-7-4-11/h1-10,20H,(H2,18,21)(H,22,23)
Bioactivity Comments
AKN-028 shows cytotoxic activity in several acute myeloid leukemia (AML) cell lines [1].
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
fms related receptor tyrosine kinase 3 Primary target of this compound Hs Inhibitor Inhibition 8.2 pIC50 - 1
pIC50 8.2 (IC50 6x10-9 M) [1]
KIT proto-oncogene, receptor tyrosine kinase Primary target of this compound Hs Inhibitor Inhibition 7.5 pIC50 - 1
pIC50 7.5 (IC50 2.9x10-8 M) [1]
Description: Inhibition of KIT autophosphorylation in human AML M07 cells which overexpress KIT